Back to CLDX
PRICE T ROWE ASSOCIATES INC /MD/ → CLDX
PRICE T ROWE ASSOCIATES INC /MD/ CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
8
Latest value
$4.3M
Q3 2026
Peak value
$169.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $53.2M |
| Q4 2025 | $2.2M |
| Q1 2026 | $2.9M |
| Q1 2026 | $63.3M |
| Q2 2026 | $169.8M |
| Q2 2026 | $4.6M |
| Q3 2026 | $137.8M |
| Q3 2026 | $4.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.3M | 132.7K | — | — |
| Q3 2026 | $137.8M | 4.25M | — | — |
| Q2 2026 | $4.6M | 123.2K | — | — |
| Q2 2026 | $169.8M | 4.56M | — | — |
| Q1 2026 | $63.3M | 2.00M | — | — |
| Q1 2026 | $2.9M | 90.3K | — | — |
| Q4 2025 | $2.2M | 81.0K | — | — |
| Q4 2025 | $53.2M | 1.96M | — | — |
Other funds holding CLDX
$343.1M
$250M
$240.9M
$223.4M
$212.9M